According to a new report, published by KBV research, The Global Eubiotics Market size is expected to reach $7.2 billion by 2028, rising at a market growth of 7.6% CAGR during the forecast period.
The Probiotics segment acquired maximum revenue share in the Global Eubiotics Market by Product in 2021, thereby, achieving a market value of $2.7 billion by 2028. A probiotic is an alive microbial feed that maintains the microbial balance in the intestine. It is a nondigestible food that helps bacteria proliferate in the colon. A combo of probiotics and prebiotics is known as a symbiotic or eubiotic.
The Immunity segment is showcasing a CAGR of 8% during (2022 - 2028). Not only has the immune system evolved alongside a diverse gut flora to produce protections against infections, but it has also developed a tolerance for beneficial microorganisms. The immune system and the microbiota communicate from the moment the body comes into contact with bacteria during birth.
The Solid segment is leading the Global Eubiotics Market by Form in 2021, thereby, achieving a market value of $4.1 billion by 2028. It is because Flakes and cross-linked beadlet are the forms of solid feed. The beadlet technology reliably preserves active chemicals from mechanical and heat stress in feed production, making them more stable and accessible. This expansion was ascribed to the development of novel solid products such as cross-links, beadlets, and flakes beadlets, as well as a substantial shift toward solid form due to the advancement of innovative solid eubiotics products with enhanced carrier capacity.
The Cattle Feed segment has shown growth rate of 7.8% during (2022 - 2028). In animal husbandry, there are various feeding systems for cattle. Grass is typically the forage that makes up the majority of a pastured animal's diet. Feedlot cattle are given hay supplemented with grain, soy, and other additives to boost the feed's energy density.
The Europe market dominated the Global Eubiotics Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2.9 billion by 2028. The North America market is estimated to grow at a CAGR of 6.8% during (2022 - 2028). Additionally, The Asia Pacific market would witness a CAGR of 8.6% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/eubiotics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Koninklijke DSM N.V., Novozymes A/S, BASF SE, DuPont de Nemours, Inc., Chr. Hansen holding A/S, Lallemand, Inc., Lesaffre Group, Kemin Industries, Inc., Cargill Corporation, and Calpis Co., Ltd.
By Product
By Application
By Form
By End-use
By Geography
Companies Profiled
Unique Offerings 
